Substance / Medication

Ascorbic acid

Overview

Active Ingredient
ascorbic acid
RxNorm CUI
1151

Indications

Dialyvite 3000 is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.

Labeler: Hillestad Pharmaceuticals USAUpdated: 2027-01-27T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Malaria Is Associated with Diminished Levels of Ascorbic Acid: A Systematic Review and Meta-Analysis.
Kotepui Manas, Mahittikorn Aongart, Anabire Nsoh Godwin et al. · Antioxid Redox Signal · 2024
PMID: 37337659Meta-Analysis
Therapeutic Impact of Ascorbic Acid on Oral and Periodontal Tissues: A Systematic Literature Review.
Ruzijevaite Gabriele, Acaite Enrika, Jagelaviciene Egle · Medicina (Kaunas) · 2024
PMID: 39768921Meta-AnalysisFull text (PMC)
Potential Utilisation of Secretome from Ascorbic Acid-Supplemented Stem Cells in Combating Skin Aging: Systematic Review of A Novel Idea.
Wahyuningsih Komang Ardi, Pangkahila Wimpie I, Weta I Wayan Weta et al. · Cell J · 2023
PMID: 37718762Meta-AnalysisFull text (PMC)
The Use of Hydrocortisone, Ascorbic Acid and Thiamine in Patients with Sepsis and Septic Shock - A Systematic Review.
Wang Kunkun, Yin Ling, Song Yang et al. · J Pharm Pract · 2023
PMID: 35465689Meta-Analysis
Benefits of combination therapy of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock: A systematic review.
Lee Young Ran, Vo Kandace, Varughese Jincy Thazhampallatu · Nutr Health · 2022
PMID: 34039089Meta-Analysis
Bleeding tendency and ascorbic acid requirements: systematic review and meta-analysis of clinical trials.
Hujoel Philippe P, Kato Tomotaka, Hujoel Isabel A et al. · Nutr Rev · 2021
PMID: 33517432Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ascorbic acid (substance)
SNOMED CT
43706004
UMLS CUI
C0003968
RxNorm CUI
1151
Labeler
Hillestad Pharmaceuticals USA

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.